Periostin antibodies and methods of using the same
US12281171B2 · kind B2 · utility
0Cited by
21References
13Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 19, 2019 |
| Grant date | Apr 22, 2025 |
| Priority date | — |
| Expiry date | Jun 18, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/732
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present inventors have developed antigen-binding reagents and antigen-binding conjugates that recognize a cancer-specific glycan (carbohydrate) modification on the human Periostin protein. Various in vitro and in vivo diagnostic and/or therapeutic methods using these compositions are also disclosed herein specifically for treating cancers that have amplification of the Mgat3 gene.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.